Background: Recently, certain forms of early repolarization (ER) on electrocardio-
ventricular repolarization may lead to an increased risk of ventricular tachyarrhythmias. In particular, the presence of certain forms of abnormal early repolarization (ER) on the 12-lead electrocardiogram (ECG) has been associated with an increased incidence of sudden cardiac death in the general population, 8, 9 whether or not abnormal ER may contribute to SUDEP is unknown.
The goals of this study were to compare the prevalence, characteristics, and prognosis of ER in patients with known epilepsy to analogous findings in age-and sex-matched healthy controls.
| MATERIALS AND METHODS

| Study population and data collection
ECG results in consecutive patients with epilepsy and age-and sexmatched normal controls were obtained retrospectively using medical records maintained at the University of Occupational and Environmental Health, Japan. The study protocol was approved by the Ethical Committee at the University of Occupational and Environmental Health, Japan.
| Epilepsy group
The epilepsy group included 366 consecutive patients (mean age, 
| Control group
The control group consisted of 140 age-and sex-matched subjects (mean age, 31 ± 12 years; 50% men). Controls were selected randomly from patients hospitalized for confirmation of abnormalities of urinary findings through renal biopsy at the Second Department of Internal Medicine at the University of Occupational and Environmental Health, Japan. All control subjects were determined to have normal renal function and no electrolyte imbalance in blood samples. Controls were excluded if they were using any cardioactive medications and/or had histories of cerebrovascular and/or cardiovascular disease or heart failure.
| Antiepileptic therapy and suppression of epilepsy
Epilepsy patients were treated with antiepileptic medications, neurosurgical therapy, or both. The antiepileptic medications varied among patients but included sodium channel blockers (carbamazepine, phenytoin, lamotrigine, zonisamide, and topiramate), calcium channel blockers (ethosuximide and zonisamide), or others (sodium valproate and levetiracetam). Suppression of epilepsy was defined as freedom from seizure for more than 1 year of follow-up with any therapy. 10 
| Electrocardiographic measurements
Resting 12-lead ECGs were performed in all patients and recorded as part of the patient's initial evaluation. All ECG readings were obtained in the same laboratory environment using automated software (Fukuda Denshi Co, Ltd, Tokyo, Japan), and were verified manually by two cardiac electrophysiologists without knowledge of each subject's clinical condition.
The recording device specifications used in this study were: sampling rate: 8000/seconds, filter criteria: AC, −20 dB or less at 50 to 60 Hz; EMG, −3 dB (−6 dB/octave) at 25 to 35 Hz; drift, −3 dB at 0.5 to 0.255 Hz. Additional filtering algorithms were not deemed necessary and, in any case, the latter methods introduce issues with de-noising artifact that are best avoided.
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The QT interval was measured between the onset of the QRS complex and the terminal point of the T-wave or if necessary the tangent of the terminal T-wave as it intersects the isoelectric line on the ECG (ie, presence of prominent U-wave). 12 Only monophasic, clearly defined T-waves were included in the measurements. If the end of the T-wave was not reliably identified, or if the T-wave was isoelectric or less than 0.05 mV in amplitude, then more clearly observed T-waves during the same 12-lead ECG were selected to measure QT intervals. The QT interval was measured using 8 to 12
surface ECG leads (mean, 10 ± 1 leads) for each subject. 
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were used to calculate the QTc interval.
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The presence or absence of ER on 12-lead ECG and ER characteristics was analyzed and measured in accordance with the ECG criteria in the consensus report on ER pattern. 16 Abnormal ER was defined by the following criteria:
(1) Presence of an end-QRS notch or slurring was identified if it occurred on the final 50% downslope of a prominent R-wave. If a notch was identified, it had to lie entirely above the baseline.
Similarly, if a slurring was identified, its onset also had to be above the baseline. End-QRS slurring was an apparent slowing of the inscription of the waveform at the end of the QRS complex that merges with the ST-segment of that QRS complex.
(2) Peak amplitude of an observed J-wave had to be more than or equal to 0.1 mV in two or more contiguous leads of the 12-lead ECG, excluding leads V 1 to V 3 .
(3) The QRS duration had to be less than 120 milliseconds.
ECG results were recorded at a sweep speed of 25 mm/seconds and calibration of 1 mV/10 mm using more than 0.1-mV QRS-ST junction (Jpoint) elevation above baseline in two or more inferior or lateral leads. 8 The ST-segment morphology was further classified as concave/ rapidly ascending or horizontal/descending. 9, 16 A concave/rapidly ascending ST-segment (ER with an ascending ST-segment) was defined as an elevation more than or equal to 0.1 mV within 100 milliseconds after the J-termination point or throughout the segment. A horizontal/descending ST-segment (ER with a horizontal or descending ST segment) was defined as an elevation less than or equal 0.1 mV within 100 millisecond after the J-termination point or throughout the segment, as shown in Figure 1 .
| Statistical analysis
Continuous variables are expressed as mean ± standard deviation (SD) and were compared using Student's t test or the Mann-Whitney U test.
Categorical variables are presented as counts and percentages in each group and were compared using the χ 2 test. The paired t test was used to make comparisons in patients before and after antiepileptic drugs (AED) therapy and with initial evaluation and after seizure suppression.
Univariable and multivariable logistic regression analyses were performed to estimate the odds ratios (ORs) for ER. Variables entered in the model included age, male gender, ECG measurements, antiepileptic drugs, classification, and duration of epilepsy; P < 0.05 was considered statistically significant. All statistical analyses were performed using JMP version 10.0 (SAS Institute Inc, Cary, NC).
3 | RESULTS
| Patient characteristics
Of the 366 epilepsy patients, 12 were excluded due to the presence of cardiovascular disease in one, complete right bundle branch block (QRS duration ≥120 ms) in two, and incomplete clinical data in nine patients. Consequently, findings in a total of 354 epilepsy patients (mean age, 33 ± 16 years; 54% men) were analyzed.
The demographic, clinical, and ECG characteristics of both epilepsy and control groups are summarized in Table 1 . No patient in either group had findings suggesting underlying organic heart disease, which included ischemic heart disease or was receiving antiarrhythmic therapy or any cardioactive medications. There were no differences in major co-morbidities, heart rate, PQ intervals, or QRS durations between the two groups. The mean QT intervals were significantly shorter in the epilepsy group than in the controls. After correction, the QTc intervals measured by
Fridericia formula remained significantly shorter in the epilepsy group than in the control group, but there was no significant difference between the two groups when using Bazett's formula (Table 1 ).
The median duration of diagnosed epilepsy history at the initial evaluation was 7 years (25th-75th percentile, 1-18 years).
Regarding seizure type, focal epilepsy was present in 262 (74%) patients, whereas generalized epilepsy was present in 92 (26%) patients. Sodium channel-blocking antiepileptic drugs were the most often used among treated epilepsy patients (n = 218, 61%).
The study flowchart for epilepsy patients is shown in Figure 2 .
(A) (B) The overall incidence of abnormal ER with J peak more than or equal to 1.0 mm (0.1 mV) was higher in the epilepsy group (92 patients, 26.0%) than in the control group (18 patients, 12.9%; P = 0.001) at the initial evaluation. In addition, the incidence of ER was significantly higher in the inferior ECG leads (P = 0.002) in epilepsy patients than in the control group. This was not the case for the lateral leads (P = 0.40).
Of the 110 subjects with ER (92 patients in the epilepsy group and 18 subjects in the control group), ER with a horizontal or descending ST segment was more prevalent in the epilepsy group (69 patients, 19.5%) than in the control group (nine patients, 6.4%; P < 0.001), whereas ER with an ascending ST segment occurred with equal frequency among the epilepsy group and control group (6.5% vs 6.4%; P = 0.98). Furthermore, the incidence of abnormal ER in epilepsy patients was greater in males (64.8%).
| Effects of AEDs on ECG findings (Table 3)
Re-assessment of 12-lead ECGs was performed both before and after introducing AEDs in 36 epilepsy patients. Incidence of abnormal ER was the same (nine patients, 25.0%; P = 1.0) as before AED therapy, and there were no significant AED-induced changes in the amplitude of the J peak (1.6 ± 0.4 mm before vs 1.5 ± 0.5 mm after; P = 0.68) before and after the use of AEDs.
| Predictors for ER in the epilepsy group
As shown in Table 4 , mean age, heart rate, QT, and QTc intervals, prescriptions for sodium channel-blocking and calcium channelblocking drugs, and duration of epilepsy were not significant predictors of abnormal ER in epilepsy patients by univariable analysis. Male sex was the only significant predictor of ER for epilepsy patients in both the univariable (P = 0.01) and multivariable (P = 0.03) analysis.
| Effects of epilepsy control on ECG findings (Table 5)
Repeat ECGs were obtained both at the initial evaluation and at regular follow-up visits for a mean of 2.8 ± 1.8 years. Seizure suppression as defined earlier was achieved with AED therapy in 64 of 137 patients. There were no significant differences in ECG findings between initial evaluation and after seizure suppression in regard to either the incidence of abnormal ER (17 patients [26.6%] at initial evaluation vs 16 patients [25.0%] after remission; P = 0.84) or the amplitude of the J peak (1.9 ± 0.9 mm at initial evaluation vs 1.6 ± 0.7 mm after remission, P = 0.052).
| Follow-up
Patients were followed for a median duration of 7 years (25th-75th percentile, 3-10 years). SUDEP occurred in two patients during follow-up. The first death was a 25-year-old male, who was diagnosed with left temporal lobe epilepsy that began when he Figure 3B , did not show any abnormalities in QRS complex and STsegment morphology.
4 | DISCUSSION
| Main findings
This study provides five principal observations regarding abnormal ER in epilepsy patients compared to age/sex-matched control subjects. First, we found a higher prevalence of abnormal ER in epilepsy patients than in the age-and sex-matched controls.
Second, there was a significantly greater likelihood for ER with a horizontal or descending ST segment to be most apparent in the inferior leads. Third, the prevalence of abnormal ER did not differ significantly before and after introducing AEDs. Fourth, there were no notable changes in ER characteristics in epilepsy patients after achieving AED-induced seizure suppression with therapeutic interventions. Finally, SUDEP was observed in 2 of 356 epilepsy patients (0.56%) during a median follow-up period of 7 years, with preexisting abnormal ER present in one of these two individuals.
| Increased risk of arrhythmic death in patients with epilepsy
The prevalence of abnormal ER in the general population ranges from 3.3% to 12.9%, and its impact on prognosis has been examined in recent studies. 8, 9 In a community-based study of 10 864 subjects, ER in the inferior ECG leads was associated with a relative risk of cardiac death of 1.28 (P = 0.03), and ER with a Jpoint elevation more than 0.2 mV in the inferior ECG leads was associated with a relative risk of cardiac death of 2.98 (P < 0.001) and a relative risk of sudden arrhythmic death of 2.92 (P = 0.01). 8 These results suggested that ER in the inferior leads was a stronger predictor of death from cardiac causes than other wellknown ECG risk markers, such as a prolonged QTc interval or left ventricular hypertrophy. 8 In addition, the correlation between variations in ST-segment morphology after ER and prognosis in 10 864 middle-aged subjects has been investigated. 8 In the latter study, higher amplitude ER in inferior leads and horizontal/ descending ST-segment variant increased the hazard ratio of arrhythmic death to 2.14 (95% confidence interval, 1.56-6.30). In the current study, there was significantly greater prevalence of ER
Before AED therapy, n = 36
After AED therapy, n = 36 P value Values are reported as mean ± standard deviation or n (%). with a horizontal or descending morphology observed in epilepsy patients compared with those in the control group, and the incidence of abnormal ER in epilepsy patients was more common in males (64.8%). Male predominance was similar to the incidence of ER in a previous report on healthy subjects (64.6%). reported that ajmaline, a class 1a antiarrhythmic drug, decreased J-wave amplitude significantly. In addition, Nam et al 19 reported that diagnostic tests for Brugada-type ECG patients using provocation by sodium channel blockers were all negative in ER syndrome patients.
T A B L E 4 Predictors for early repolarization in the epilepsy group
These reports support our present results that the prevalence of ER was unchanged and J-peak amplitude was slightly decreased, but not significantly, before and after AED exposure in the epilepsy group (Table 3) .
| Relationship between epilepsy and abnormal ECG findings
Although the relationship between ECG repolarization abnormalities and the pathogenesis of epilepsy itself remains unclear, interaction between the heart and the brain may be a common underlying mechanism. In this regard, one can speculate that ER might be driven by autonomic influences associated with subclinical seizure activity or seizure susceptibility; however, such a relationship seems unlikely. 20 Further assessment of this possibility is needed. Another possibility is that abnormal QRS morphologies may reflect the presence of clinical or subclinical ischemic heart disease in patients with epilepsy. In fact, it has been reported that there is a slightly higher incidence of ischemic heart disease in patients with epilepsy. 21 However, the mean age in our study patients was relatively young (mean, 33 years old) and none had any symptoms (ie, chest pain, chest oppression, or chest discomfort) suggestive of the presence of ischemic heart disease at the time of enrollment or during the entire follow-up periods.
| Study limitations
The interpretation of the findings in this study is impacted by several important limitations. First, it was retrospective in design and the data was acquired from a single center. Second, inasmuch as the epilepsy population was larger than the control population, the frequency of abnormal ECG findings in the controls might be underestimated. In such cases, while the observed frequency of abnormality in the epilepsy group is unaltered, there it is possible that an underestimate in the control group could introduce a bias in terms of relative frequency of abnormal findings in the two populations. Third, despite the fact that the sample population was relatively large with regard to ECG findings in epilepsy patients, thereby permitting a meaningful analysis of the data and identification of significant between-group differences, it was small and of relatively short follow-up with respect to what is needed given low SUDEP event rates. In this retrospective cohort study, SUDEP occurred in only 2 of 356 patients during the median follow-up period of 7 years. These two patients had multiple identified risk factors for SUDEP, including generalized tonic-clonic seizures, refractory epilepsy necessitating antiepileptic drug polytherapy, long history of epilepsy, younger age at epilepsy onset, and frequent seizures. [2] [3] [4] However, only one of the two patients showed abnormal ER (J-wave) in lateral leads on ECG.
Therefore, we cannot confidently address any correlation between ER abnormalities and the incidence of sudden death. Values are reported as mean ± standard deviation or n (%).
| CONCLUSIONS
Certain ECG abnormalities (ie, presence of ER in the inferior leads, ER with a horizontal or descending ST segment, known to be associated with an increased risk of sudden cardiac death in the general population, are more prevalent in patients with epilepsy). These observations may provide further insight into the apparent increased risk for fatal arrhythmias and SUDEP in these individuals. A prospective long-term follow-up study is needed to better address these issues.
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